Insider filing · AMGN
Nancy A. Grygiel
SVP & CCO
profile →
Amgen Inc.
AMGN · Healthcare · 48 filings in 24 months
ticker →
Nancy A. Grygiel sold $484K of Amgen (AMGN)
Executed Feb 5 2025, disclosed Feb 6 2025, 1 day later.
Value, as filed
$484K
1,589 sh × $304.47
Executed
Feb 5 2025
the trade date, as filed
Disclosed
Feb 6 2025
1 day after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
NGNancy A. Grygiel (SVP & CCO) filed 3 Form 4 reports in the trailing twelve months (0 purchases, 3 sales), most often in Amgen Inc. (AMGN). The largest single filing was $1.2M of AMGN (2,970 sh across 2 lots, as filed), executed Aug 6.
The name
AMGNHealthcare · Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Nancy A. Grygiel in AMGN
AMGNSALE
Amgen Inc.
$1.2M2,970 sh across 2 lots
Exec Aug 6
Filed Aug 7 · 6:45 PM ET AMGNSALE Amgen Inc. $400K
1,237 sh × $323.73
Exec May 4
Filed May 5 · 5:30 PM ET AMGNSALE Amgen Inc. $1.1M
3,139 sh across 2 lots
Exec Nov 20 2025
Filed Nov 21 2025 · 5:30 PM ET AMGNSALE Amgen Inc. $376K
1,267 sh × $296.99
Exec Aug 20 2025
Filed Aug 22 2025 · 5:30 PM ET